Harvard Apparatus Regenerative Technology Receivables 2013-2025 | HRGN

Harvard Apparatus Regenerative Technology receivables from 2013 to 2025. Receivables can be defined as the total amount of collectibles for a company

Harvard Apparatus Regenerative Technology Receivables 2013-2025 | HRGN

Harvard Apparatus Regenerative Technology receivables from 2013 to 2025. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$147.7B
CVS Health (CVS)$90.7B
Elevance Health (ELV)$69.8B
Cencora (COR)$56.2B
DiDi Global (DIDIY)$27.9B
Labcorp Holdings (LH)$23.1B
Natera (NTRA)$22.7B
BioMerieux (BMXMF)$17.4B
EUROFINS SCIENT (ERFSF)$14.5B
ICON (ICLR)$13.9B
Medpace Holdings (MEDP)$13.2B
CochLear (CHEOY)$12.9B
Solventum (SOLV)$12.6B
Viatris (VTRS)$12.1B
Caris Life Sciences,�Inc (CAI)$10.8B
Revvity (RVTY)$10.6B
Avantor (AVTR)$9.1B
Charles River Laboratories (CRL)$8.1B
Sonic Healthcare (SKHHY)$7.7B
HealthEquity (HQY)$7.7B
Bausch + Lomb (BLCO)$5.1B
Sotera Health (SHC)$4.7B
BrightSpring Health Services (BTSG)$4.2B
Amplifon S.p.A (AMFPF)$3.9B
GeneDx Holdings (WGS)$3.6B
Alignment Healthcare (ALHC)$3.1B
KindlyMD (NAKA)$3B
Concentras Parent (CON)$2.9B
Surgery Partners (SGRY)$2.9B
Organon (OGN)$2.4B